Pharmaceutical Care for One Patient with Colon Cancer Complicated with Herpes Zoster after Chemotherapy Combined with Cetuximab
Objective To explore the role of a clinical pharmacist in the treatment of herpes zoster caused by chemotherapy combined with cetuximab in one patient with colon cancer in order to provide reference for pharmaceutical care for such patients.Methods One clinical pharmacist participated in the treatment of a patient with colon cancer complicated with herpes zoster after chemotherapy combined with cetuximab.The patient was diagnosed with colon cancer and received chemotherapy combined with targe-ted therapy of cetuximab.Herpes zoster developed after 2 cycles of therapy.The physician prescribed acy-clovir 500 mg intravenous infusion for antiviral therapy,1.5 mg cobamamide intramuscular for nerve nutri-tion,and calamine lotion for external use.The clinical pharmacist referred to related literature,found out more about the diagnosis and treatment of herpes zoster,assisted the physician in optimizing the selection and clinical application of antiviral drugs and herpes zoster neuralgia(PHN)drugs,and provided pharma-ceutical care for the patient.Results The physician adopted the pharmacist's advice.After symptomatic treatment,the patient's symptoms related to herpes zoster improved significantly,and then received anti-tumor treatment.Conclusion During the treatment of herpes zoster in a patient with colon cancer after chemotherapy combined with cetuximab,the clinical pharmacist can assist the physician in improving the treatment plan,informing the patient of safe and rational use of drugs and providing pharmaceutical care,which is of great significance for the therapeutic effect.
colon cancerchemotherapycetuximabherpes zosterpharmaceutical care
NETL
NSTL
万方数据
